[1]
|
Poll-The, B.T., et al. (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). American Journal of Human Genetics, 42, 422-434.
|
[2]
|
Wanders, R.J. and Waterham, H.R. (2006) Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochimica et Biophysica Acta, 1763, 1707-1720.
doi:10.1016/j.bbamcr.2006.08.010
|
[3]
|
El Hajj, H.I. et al. (2012) The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adreno-leukodystrophy). Endocrinology, 153, 2568-2575.
doi:10.1210/en.2012-1137
|
[4]
|
Cherkaoui-Malki, M., et al. (2012) Hepatic steatosis and peroxisomal fatty acid beta-oxidation. Current Drug Metabolism, 13, 1412-1421.
doi:10.2174/138920012803762765
|
[5]
|
Reddy, J.K. (2004) Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: Biotic and xenobiotic sensing. American Journal of Pathology, 164, 2305-2321. doi:10.1073/pnas.1009176107
|
[6]
|
Delille, H.K., Alves, R. and Schrader, M. (2009) Biogenesis of peroxisomes and mitochondria: Linked by division. Histochemistry and Cell Bi-ology, 131, 441-446.
|
[7]
|
Girzalsky, W., Saffian, D. and Erd-mann, R. (2010) Per- oxisomal protein translocation. Biochimica et Biophysica Acta, 1803, 724-731.
|
[8]
|
Bagattin, A., Hugendubler, L. and Mueller, E. (2010) Transcriptional coacti-vator PGC-1α promotes peroxisomal remodeling and bioge-nesis. Proceedings of the Na- tional Academy of Sciences, 107, 20376-20381.
|
[9]
|
Cherkaoui-Malki, M., et al. (2001) Identi-fication of novel peroxisome proliferator-activated receptor alpha (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene Expression, 9, 291-304.
|
[10]
|
Vluggens, A. and Reddy, J.K. (2012) Nuclear receptors and transcription factors in the development of fatty liver disease. Current Drug Metabolism, 13, 1422-1435.
doi:10.2174/138920012803762710
|
[11]
|
Forman, B.M., Chen, J. and Evans, R.M. (1997) Hypol- ipidemic drugs, polyunsatu-rated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proceedings of the National Academy of Sciences, 94, 4312-4317.
doi:10.1073/pnas.94.9.4312
|
[12]
|
Gottlicher, M., et al. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proceedings of the National Academy of Sciences, 89, 4653-4657. doi:10.1073/pnas.89.10.4653
|
[13]
|
Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by perox- isome proliferators. Nature, 347, 645-650.
doi:10.1038/347645a0
|
[14]
|
Fan, C.Y., et al. (1998) Steatohe-patitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for per- oxisome proliferator-activated receptor alpha natural lig- and metabolism. Journal of Biological Chemistry, 273, 15639-15645. doi:10.1074/jbc.273.25.15639
|
[15]
|
Huang, J., et al. (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. The American Jour- nal of Pathology, 179, 703-713.
doi:10.1016/j.ajpath.2011.04.030
|
[16]
|
Vluggens, A., et al. (2010) Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Laboratory Investigation: A Journal of Technical Methods and Pathology, 90, 696-708.
|
[17]
|
Ferdinandusse, S., et al. (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Human Mutation, 28, 904-912.
doi:10.1002/humu.20535
|
[18]
|
Wei, H., et al. (2000) Pharma-cological induction of peroxisomes in peroxisome biogenesis disorders. Annals of neurology, 47, 286-296.
doi:10.1002/1531-8249(200003)47:3<286::AID-ANA3>3.0.CO;2-B
|
[19]
|
Paintlia, M.K., et al. (2008) Lipopolysaccha-ride-induced peroxisomal dysfunction exacerbates cerebral white matter injury: Attenuation by N-acetyl cysteine. Experimental Neurology, 210, 560-576.
doi:10.1016/j.expneurol.2007.12.011
|
[20]
|
Baarine, M., et al. (2009) Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): Potential models for the study of peroxisomal disorders associated with dysmyelination processes. Journal of Neurochemistry, 111, 119-131.
doi:10.1111/j.1471-4159.2009.06311.x
|
[21]
|
Schrader, M., Krieglstein, K. and Fahimi, H. D. (1998) Tubular peroxisomes in HepG2 cells: Selective induction by growth factors and ara-chidonic acid. European Journal of Cell Biology, 75, 87-96.
doi:10.1016/S0171-9335(98)80051-4
|
[22]
|
Savary, S., et al. (2012) Fatty acids-induced lipotoxicity and inflammation. Current Drug Metabolism, 13, 1358- 1370. doi:10.2174/138920012803762729
|
[23]
|
Gondcaille, C., et al. (2005) Phenylbutyrate up-regulates the adrenoleukodystro-phy-related gene as a nonclassical peroxisome proliferator. Journal of Cell Biology, 169, 93-104. doi:10.1083/jcb.200501036
|
[24]
|
Zhang, X., et al. (2006) Peroxisome proliferator-activated receptor alpha-independent pe-roxisome proliferation. Biochemical and Biophysical Research Communications, 346, 1307-1311. doi:10.1016/j.bbrc.2006.06.042
|
[25]
|
Gloerich, J., et al. (2005) A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARα-dependent and -independent pathways. Journal of Lipid Research, 46, 716-726.
doi:10.1194/jlr.M400337-JLR200
|
[26]
|
DeLuca, J.G., et al. (2000) Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation: Effects of PPARγ/delta-specific agonists in PPARαlphanull mice. Moecular Pharmacology, 58, 470-476.
|
[27]
|
Jia, Y., et al. 2003) Overexpression of peroxisome proliferator-activated recep-tor-alpha (PPARα)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydra- tase/dehydrogenase enzymes of peroxisomal beta-oxidation system. Journal of Biological Chemistry, 278, 47232- 47239. doi:10.1074/jbc.M306363200
|
[28]
|
Contreras, M.A., et al. (2000) Endotoxin induces structure-function alterations of rat liver peroxisomes: Kupffer cells released factors as possible modulators. Hepatology, 31, 446-455. doi:10.1002/hep.510310226
|
[29]
|
Dhaunsi, G.S., Hanevold, C.D. and Singh, I. (1994) Im pairment of peroxisomal beta-oxidation system by endotoxin treatment. Molecular and Cellular Biochemistry, 135, 187-193. doi:10.1007/BF00926522
|
[30]
|
Khan, M., et al. (1998) Cyto-kine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: Implication for X-adrenoleukodystrophy. Journal of neuro- chemistry, 71, 78-87.
doi:10.1046/j.1471-4159.1998.71010078.x
|
[31]
|
Paintlia, M.K., et al. (2008) Modulation of peroxisome proliferator-activated receptoralpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. Journal of Neurochemistry, 105, 956-970.
doi:10.1111/j.1471-4159.2007.05199.x
|
[32]
|
Schilling, J., et al. (2011) Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxi-some proliferator-activated receptor gamma coactivator-1 signaling. Circulation: Heart Failure, 4, 474-482.
doi:10.1161/CIRCHEARTFAILURE.110.959833
|